Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Scott Innis

1PUBLICATIONS

25CO-AUTHORS

Molecular targets

Featured researcher

Get your video featured.

Publish with JoVE

Featured researcher

Get your video featured.

Publish with JoVE

Publications (1)

Sort by Publication Date:

|Dec 11, 2024

A Phase I Study of FHD-609, a Heterobifunctional Degrader of Bromodomain-Containing Protein 9, in Patients with Advanced Synovial Sarcoma or SMARCB1-Deficient Tumors.

J Andrew Livingston, Jean-Yves Blay, Jonathan Trent

Pageof 1

Frequent Collaborators

1 joint publications

J Andrew Livingston

1 joint publications

Jean-Yves Blay

1 joint publications

Jonathan Trent

1 joint publications

Claudia Valverde

1 joint publications

Mark Agulnik

1 joint publications

Mrinal Gounder

1 joint publications

Axel Le Cesne

1 joint publications

Meredith McKean

1 joint publications

Michael J Wagner

1 joint publications

Silvia Stacchiotti

Frequent Collaborators

1 joint publications

J Andrew Livingston

1 joint publications

Jean-Yves Blay

1 joint publications

Jonathan Trent

1 joint publications

Claudia Valverde

Top Related Videos

Characterizing Exon Skipping Efficiency in DMD Patient Samples in Clinical Trials of Antisense Oligonucleotides

Characterizing Exon Skipping Efficiency in DMD Patient Samples in Clinical Trials of Antisense Oligonucleotides

Published on : May 07, 2020

See more related videos

Top Related Videos

Characterizing Exon Skipping Efficiency in DMD Patient Samples in Clinical Trials of Antisense Oligonucleotides

Characterizing Exon Skipping Efficiency in DMD Patient Samples in Clinical Trials of Antisense Oligonucleotides

Published on : May 07, 2020

See more related videos